JENNIFER POSEY to Whole Genome Sequencing
This is a "connection" page, showing publications JENNIFER POSEY has written about Whole Genome Sequencing.
Connection Strength
0.092
-
Implementing evidence-based assertions of clinical actionability in the context of secondary findings: Updates from the ClinGen Actionability Working Group. Genet Med. 2024 Aug; 26(8):101164.
Score: 0.050
-
IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease. Hum Genet. 2021 Sep; 140(9):1299-1312.
Score: 0.041